Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensified Chemoradiotherapy for Anaplastic Thyroid Cancer
NCT00004089Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 1999
- Primary completion
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel, fluorouracil and hydroxyurea in anaplastic thyroid cancer (ATC), sponsored by National Cancer Institute. Primary endpoints: Complete Response Rate, Overall Response Rate and 4 more. Started Aug 1999; status: completed.
02
Drugs
paclitaxelfluorouracilhydroxyurea
03
Conditions
anaplastic thyroid cancer (ATC)
Beyond the preview
Go deeper on NCT00004089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004089.